VOXAMIN-100 Tablet

About VOXAMIN-100 Tablet

VOXAMIN-100 is a 100 mg tablet containing fluvoxamine maleate, an SSRI-type antidepressant. It is prescribed for obsessive-compulsive disorder and certain other conditions, and the doctor decides the dose and course.

There are 4 brands of Fluvoxamine Maleate listed in Bangladesh.

What is VOXAMIN-100 Tablet?

VOXAMIN-100 is a tablet from Renata PLC. that contains fluvoxamine maleate 100 mg. It belongs to a group of antidepressants known as SSRIs. It works on serotonin, a chemical messenger in the brain. Doctors prescribe it mainly for obsessive-compulsive disorder, and it may also be used in some depressive illness, panic disorder, eating disorders and chronic tension headache. It is a prescription medicine, so the dose and how long it is taken are set by the doctor after assessing the patient. Do not start, stop or change it without medical advice.

Uses of VOXAMIN-100

VOXAMIN-100 is used most often for obsessive-compulsive disorder, where unwanted repeated thoughts and rituals are troublesome. Doctors may also prescribe fluvoxamine for some forms of depressive illness, panic disorder, eating disorders and chronic tension headache. Only a qualified doctor can decide whether it suits a particular person, and the dose and course are set by the doctor.

How to use VOXAMIN-100

Take VOXAMIN-100 exactly as the doctor tells you. The doctor decides the dose, how often it is taken and for how long. Swallow the tablet as advised, and do not stop it suddenly on your own, because stopping an antidepressant needs medical guidance. If you miss a dose, ask your doctor or pharmacist what to do. Tell your doctor about any other medicines you take before starting.

Side effects of VOXAMIN-100

Some people notice nausea, drowsiness, trouble sleeping, weakness, nervousness, indigestion, sweating, loss of appetite, tremor or vomiting. Others may have dry mouth, changes in sexual function, or a runny nose. Not everyone gets these effects. Tell your doctor if any effect is troublesome or does not settle, and seek medical help quickly for severe or unusual symptoms. Your doctor or pharmacist can advise on what to expect.

Safety and precautions

VOXAMIN-100 should be used only under medical supervision. Tell your doctor before starting if you have a history of mania, seizures, suicidal thoughts, heart disease, diabetes, angle-closure glaucoma, bleeding problems, or liver or kidney problems, or if you are having ECT. It may affect skilled tasks such as driving, so be careful until you know how it affects you. Pregnancy and breastfeeding need a discussion of risks and benefits with the doctor, as the medicine passes into breast milk. Do not take it with MAOIs or certain other medicines; check with your doctor or pharmacist first.

Frequently asked questions

What kind of medicine is VOXAMIN-100 and what is it used for?

VOXAMIN-100 is a tablet containing fluvoxamine maleate 100 mg, an SSRI-type antidepressant. It is prescribed mainly for obsessive-compulsive disorder and may also be used for some depressive illness, panic disorder, eating disorders and chronic tension headache. Only a doctor can decide if it is suitable for you.

Which medicines may interact with VOXAMIN-100?

It can interact with MAOIs, tizanidine, thioridazine, alosetron, pimozide, carbamazepine, sumatriptan, tacrine and tricyclic antidepressants, among others. Always tell your doctor and pharmacist about every medicine you take, including ones bought without a prescription, before starting or stopping anything.

How should VOXAMIN-100 be taken?

Take it exactly as your doctor advises. The doctor decides the dose, how often it is taken and how long the course lasts. Do not change or stop it on your own, since stopping an antidepressant needs medical guidance. Ask your doctor or pharmacist if you are unsure about anything.

Who should check with a doctor before using VOXAMIN-100?

Anyone with a history of mania, seizures, suicidal thoughts, heart disease, diabetes, angle-closure glaucoma, bleeding problems, or liver or kidney problems should speak to the doctor first. Pregnant or breastfeeding women and people having ECT also need medical advice before use.

Indications

Maprotiline Hydrochloride is indicated in-
  • Obsessive-Compulsive Disorder
  • Depressive illness
  • Panic Disorder
  • Eating Disorders
  • Chronic Tension Headache

Pharmacology

The exact mechanism of action of fluvoxamine has not been fully determined but appears to be linked to its inhibition of CNS neuronal uptake of serotonin. Fluvoxamine blocks the reuptake of serotonin at the serotonin reuptake pump of the neuronal membrane, enhancing the actions of serotonin on 5HT1A autoreceptors. Studies have also demonstrated that fluvoxamine has virtually no affinity for α1- or α2-adrenergic, β-adrenergic, muscarinic, dopamine D2, histamine H1, GABA-benzodiazepine, opiate, 5-HT1, or 5-HT2 receptors, despite having an affinity for binding to σ1 receptors.

Dosage & Administration

Adults: The recommended starting dose for Fluvoxamine Maleate Tablets in adult patients is 50 mg, administered as a single daily dose at bedtime. In the controlled clinical trials establishing the effectiveness of Fluvoxamine Maleate Tablets in OCD, patients were titrated within a dose range of 100 to 300 mg/day. Consequently, the dose should be increased in 50 mg increments every 4 to 7 days, as tolerated, until the maximum therapeutic benefit is achieved, not to exceed 300 mg per day. It is advisable that a total daily dose of more than 100 mg should be given in two divided doses. If the doses are not equal, the larger dose should be given at bedtime.

Pediatric Population (children and adolescents): The recommended starting dose for Fluvoxamine Maleate Tablets in pediatric populations (ages 8-17 years) is 25 mg, administered as a single daily dose at bedtime. In a controlled clinical trial establishing the effectiveness of Fluvoxamine Maleate Tablets in OCD, pediatric patients (ages 8-17) were titrated within a dose range of 50 to 200 mg/day. Physicians should consider age and gender differences when dosing pediatric patients. The maximum dose in children up to age 11 should not exceed 200 mg/day. Therapeutic effects in female children may be achieved with lower doses. Dose adjustment in adolescents (up to the adult maximum dose of 300 mg) may be indicated to achieve therapeutic benefit. The dose should be increased in 25 mg increments every 4 to 7 days, as tolerated until the maximum therapeutic benefit is achieved. It is advisable that a total daily dose of more than 50 mg should be given in two divided doses. If the two divided doses are not equal, the larger dose should be given at bedtime.

Elderly or Hepatically Impaired Patients: Elderly patients and those with hepatic impairment have been observed to have a decreased clearance of fluvoxamine maleate. Consequently, it may be appropriate to modify the initial dose and the subsequent dose titration for these patient groups.

Interaction

Drugs Inhibiting or Metabolized by Cytochrome P450: Fluvoxamine inhibits several cytochrome P450 isoenzymes (CYP1A2, CYP2C9, CYP3A4, and CYP2C19).

Carbamazepine: Elevated carbamazepine levels and symptoms of toxicity with coadministration (7.2).

Sumatriptan: Rare postmarketing reports of weakness, hyperreflexia, and incoordination following use of an SSRI and sumatriptan. Monitor appropriately if concomitant treatment is clinically warranted.

Tacrine: Coadministration increased tacrine C max and AUC five- and eight-fold and caused nausea, vomiting, sweating, and diarrhea.

Tricyclic Antidepressants (TCAs): Coadministration significantly increased plasma TCA levels. Use caution; monitor plasma TCA levels; reduce TCA dose if indicated.

Tryptophan: Severe vomiting with coadministration.

Diltiazem: Bradycardia with coadministration.

Propranolol or metoprolol: Reduce dose if coadministered and titrate more cautiously

Contraindications

Coadministration of tizanidine, thioridazine, alosetron, pimozide.

Serotonin Syndrome and MAOIs: Do not use MAOIs intended to treat psychiatric disorders with Fluvoxamine Maleate Tablets or within 14 days of stopping treatment with Fluvoxamine Maleate Tablets. Do not use
Fluvoxamine Maleate Tablets within 14 days of stopping an MAOI intended to treat psychiatric disorders. In addition, do not start Fluvoxamine Maleate Tablets in a patient who is being treated with linezolid or intravenous methylene blue.

Side Effects

Most common reactions in controlled trials with adult OCD and depression patients (incidence ≥5% and at least twice that for placebo) were nausea, somnolence, insomnia, asthenia, nervousness, dyspepsia, abnormal ejaculation, sweating, anorexia, tremor, and vomiting. Using the above rule, the following events were also identified: anorgasmia, decreased libido, dry mouth, rhinitis, taste perversion, and urinary frequency in patients with OCD; and agitation, depression, dysmenorrhea, flatulence, hyperkinesia, and rash in pediatric patients with OCD.

Pregnancy & Lactation

Consider both potential risks and benefits when treating a pregnant woman. Infants exposed to SSRIs late in pregnancy have developed various complications and may be at risk for persistent pulmonary hypertension of the newborn (PPHN). Fluvoxamine is secreted in human breast milk.

Precautions & Warnings

Fluvoxamine Maleate should be used with caution in patients with a history of mania, seizures, suicide, concomitant ECT, cardiac disease, diabetes mellitus, angle-closure glaucoma, history of bleeding disorders (especially gastrointestinal bleeding), hepatic and renal impairment. Fluvoxamine maleate may also impair the performance of skilled tasks (driving).

Storage Conditions

Keep below 30°C temperature, away from light & moisture. Keep out of the reach of children.

Alternative brands of Fluvoxamine Maleate

Other brands with the same generic name, cheapest first.

Medicine information is for reference only and is not medical advice. Always follow your doctor's prescription and check with a pharmacist.